Importantly, PMFs have demonstrated specific anti-obesity mechanisms through AMP-activated protein kinase activation, fatty acid oxidation promotion, and peroxisome proliferator-activated receptor-gamma (PPARγ) modulation [14,15,16]. The gene discussed is PPARG; the disease is obesity due to melanocortin 4 receptor deficiency.